Any feedback?
Literature summary for 3.4.24.75 extracted from
- Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA) (2010), J. Appl. Microbiol., 108, 723-730.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | lysostaphin can be used potentially as a topical disinfectant or decolonizing agent against methicillin-resistant Staphylococcus aureus infection on on human skin prior to operations. The combination is significantly more effective than treatment with ranalexin or lysostaphin alone, overview | Staphylococcus simulans |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Staphylococcus simulans | - |
- |
- |
Temperature Optimum [°C]
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 37 | - |
assay at | Staphylococcus simulans |
pH Optimum
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| 4 | - |
assay at | Staphylococcus simulans |
General Information
| General Information | Comment | Organism |
|---|---|---|
| additional information | lysostaphin is effective, in combination with antibiotic ranalexin, against methicillin-resistant Staphylococcus aureus infections. The combination is significantly more effective than treatment with ranalexin or lysostaphin alone | Staphylococcus simulans |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
